Published in Tubercle on September 01, 1976
Survey of pulmonary tuberculosis in south and west Wales (1976-8). Br Med J (Clin Res Ed) (1982) 1.78
Compliance of patients and physicians: experience and lessons from tuberculosis-II. Br Med J (Clin Res Ed) (1983) 1.38
Philip Ellman lecture. The modern management and therapy of pulmonary tuberculosis. Proc R Soc Med (1977) 1.19
Deaths in adults with notified pulmonary tuberculosis 1983-5. Thorax (1991) 0.90
Tuberculosis undefeated. Ir J Med Sci (1985) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med (1991) 12.89
Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ (1969) 12.55
Unlicensed and off label drug use in paediatric wards: prospective study. BMJ (1998) 8.74
Cohort study analysis with a FORTRAN computer program. Int J Epidemiol (1986) 6.66
Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr (1999) 6.43
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet (2004) 4.25
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet (1995) 3.71
Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer (1982) 3.61
Changes in annual tuberculosis notification rates between 1978/79 and 1983 for the population of Indian subcontinent ethnic origin resident in England. J Epidemiol Community Health (1986) 3.48
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis (1986) 3.46
Peak expiratory flow in normal subjects. Br Med J (1973) 3.40
The variability of measurements of casual blood pressure. II. Survey experience. Clin Sci (1966) 3.19
Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax (2001) 3.01
Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet (2004) 2.84
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer (2005) 2.81
Circumstances of death from asthma. Br Med J (Clin Res Ed) (1984) 2.71
Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. Br J Dis Chest (1984) 2.71
Changes in tuberculosis notification rates in the white ethnic group in England and Wales between 1953 and 1983. J Epidemiol Community Health (1988) 2.67
Short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis (1975) 2.59
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58
Ambiguities and inaccuracies in the notification system for tuberculosis in England and Wales. Community Med (1981) 2.55
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40
Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27
Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med (1979) 2.25
Staffing in thoracic medicine. Br Med J (1980) 2.25
Price and consumption of cigarettes: a case for intervention? Br J Prev Soc Med (1974) 2.22
Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer (2009) 2.18
Are asthma mortality rates changing? Br J Dis Chest (1985) 2.15
Conservation. High value and long life--double jeopardy for tunas and billfishes. Science (2011) 2.14
Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet (1973) 2.12
Whither short-course chemotherapy? Br J Dis Chest (1981) 2.07
Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism (1979) 2.07
A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS. Bull World Health Organ (1966) 2.04
Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Infect (1999) 2.03
Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03
The hygiene standard for chrysotile asbestos. Lancet (1978) 2.02
Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet (1988) 1.99
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer (2006) 1.99
Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1980) 1.99
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry (2005) 1.97
Bone and joint tuberculosis. A survey of notifications in England and Wales. J Bone Joint Surg Br (1984) 1.93
National study of colorectal cancer genetics. Br J Cancer (2007) 1.92
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Respiratory symptoms, lung function, and sensitisation to flour in a British bakery. Br J Ind Med (1989) 1.85
Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br J Haematol (1981) 1.83
Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory. Ann Occup Hyg (1985) 1.83
An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. Br J Cancer (1990) 1.83
A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India. Bull World Health Organ (1966) 1.82
Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet (1994) 1.78
Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer (2008) 1.77
Completeness of cancer registration: a new method for routine use. Br J Cancer (2000) 1.75
[Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy]. Bull Int Union Tuberc (1978) 1.75
Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax (1989) 1.75
Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer (2000) 1.74
Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br J Haematol (1991) 1.70
A mortality study among workers in an English asbestos factory. Br J Ind Med (1977) 1.69
Compliance of patients and physicians: experience and lessons from tuberculosis-I. Br Med J (Clin Res Ed) (1983) 1.68
HIV testing on all pregnant women. Lancet (1987) 1.66
The chemotherapy of pulmonary tuberculosis: a review. Chest (1979) 1.65
An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. Br J Ind Med (1990) 1.65
Primary drug resistance in pulmonary tuberculosis in Great Britain: second national survey, 1963. Tubercle (1966) 1.65
Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol (1996) 1.65
Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J Natl Cancer Inst (1999) 1.63
That the effects of smoking should be measured in pack-years: misconceptions 4. Br J Cancer (2012) 1.63
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res (2000) 1.62
Smoking and occupational allergy in workers in a platinum refinery. BMJ (1989) 1.60
Side effects of intermittent rifampicin. Br Med J (1971) 1.59
Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries. AIDS (1998) 1.57
Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatr (2003) 1.56
General considerations in the choice and management of regimens of chemotherapy for pulmonary tuberculosis. Bull Int Union Tuberc (1972) 1.56
Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet (1997) 1.55
Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS (1995) 1.54
HIV-1 incidence and HIV-1-associated mortality in a rural Ugandan population cohort. AIDS (1994) 1.53
Systolic blood pressure variation during the first 6 days of life. Clin Sci Mol Med (1975) 1.52
ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Health Technol Assess (2009) 1.51
Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet (1987) 1.49
Lung cancer mortality in relation to measured dust levels in an asbestos textile factory. IARC Sci Publ (1980) 1.48
Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study. BMJ (2005) 1.48
Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr (1995) 1.47
MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J (1978) 1.46
Persisting risk of nickel related lung cancer and nasal cancer among Clydach refiners. Occup Environ Med (2006) 1.42
p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene (1998) 1.41
A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer (2005) 1.40